FS DISPOSABLE INTERFACERecalls & reported problems across all models

We found 2 models of FS DISPOSABLE INTERFACE by Johnson & Johnson Surgical Vision, Inc. in the FDA's device registry (GUDID). Together they are named in 4,239 adverse event reports in the FDA's MAUDE database, received between Aug 29, 2016 and Sep 30, 2026 — classified as 356 injuries, 3,883 malfunctions.

The most frequently reported specific device problem is “Suction Problem” (2,857 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported FS DISPOSABLE INTERFACE problems

FS DISPOSABLE INTERFACE models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

• FS DISPOSABLE INTERFACE 590106AN

  KERATOME, AC-POWERED
  4,174 reports
• FS DISPOSABLE INTERFACE 660065AN

  KERATOME, AC-POWERED
  65 reports

Recent FS DISPOSABLE INTERFACE adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionSep 30, 2026Contamination

  The customer reported their patient interface with debris in contact with the patient, and no patient injury was reported.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 50942924 ↗
• MalfunctionSep 24, 2026Decrease in Suction

  It was reported by the customer that the patient interface (PI) had Suction loss during the raster pattern and the stromal bed showed a divet after the lift. There was no patient injury or surgical intervention reported. No further information was provided.NOTE: This report is against the Patient Interface. A separate report will be submitted for the FS Laser.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 50884021 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT AFTER THE PATIENT WAS TREATED WITH THE IFS FEMTOSECOND LASER ON (B)(6) 2026, THE PATIENT EXPERIENCED STRIAE IN THE RIGHT EYE (OD). THE PATIENT HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE ON (B)(6) 2026. NO FURTHER INFORMATION WAS PROVIDED. PACHYMETRY OD/LEFT EYE (OS) = 524/519. PREOP BEST CORRECTED VISUAL ACUITY (BCVA) OD = 6/5. PREOP BCVA OS = 6/5. PREOP REFRACTION OD = S -1.75 C-1.0 S 170. PREOP REFRACTION OS = S-1.50 C-0.75 A 160. 1 DAY POSTOP UNCORRECTED VISUAL ACUITY (UCVA) OD = 6/5. 1 DAY POSTOP UCVA OS = 6/5. 1 POST FLAP LIFT UCVA OD = 6/5. 1 POST FLAP LIFT UCVA OS = 6/5. NOTE: THIS REPORT IS FOR THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING SUBMITTED FOR THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25332492 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT AFTER THE PATIENT WAS TREATED WITH THE IFS FEMTOSECOND LASER ON (B)(6) 2026, THE PATIENT EXPERIENCED STRIAE IN THE RIGHT EYE (OD). THE PATIENT HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE ON THE (B)(6) 2026. NO FURTHER INFORMATION WAS PROVIDED. PACHYMETRY: OD/LEFT EYE (OS) = 548/544. PREOP BEST CORRECTED VISUAL ACUITY (BCVA) OD = 6/5. PREOP BCVA OS = 6/5. PREOP REFRACTION OD = S -6.5 C-0.75 A 155/. PREOP REFRACTION OS = S -6.5 C-0.75 A 155/S-6.25 C-0.50 A 20. 1 DAY POSTOP UNCORRECTED VISUAL ACUITY (UCVA) OD = 6/20. 1 DAY POSTOP UCVA OS = 6/7.5. 1 POST FLAP LIFT UCVA OD = 6/6. 1 POST FLAP LIFT UCVA OS = 6/5. NOTE: THIS REPORT IS AGAINST THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING FILED AGAINST THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25332247 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT AFTER THE PATIENT WAS TREATED WITH THE IFS FEMTOSECOND LASER ON (B)(6) 2026, THE PATIENT EXPERIENCED STRIAE IN THE LEFT EYE (OS). THE PATIENT HAD TO RETURN TO A DIFFERENT CLINIC FOR FLAP LIFT, WASH AND RINSE ON THE (B)(6) 2026. NO FURTHER INFORMATION WAS PROVIDED. PACHYMETRY: RIGHT EYE (OD)/OS = 519/516. PREOP BEST CORRECTED VISUAL ACUITY (BCVA) OD = 6/5 . PREOP BCVA OS = 6/5. PREOP REFRACTION OD = S-1.75 C-0.25 A 40. PREOP REFRACTION OS = S-2.25 C-0.25 A 180. 1 DAY POSTOP UNCORRECTED VISUAL ACUITY (UCVA) OD = 6/6. 1 DAY POSTOP UCVA OS = 6.12. 1 POST FLAP LIFT UCVA OD = 6/12. 1 POST FLAP LIFT UCVA OS = 6/5. THIS REPORT IS FOR THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING SUBMITTED FOR THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25332140 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN JANUARY AND MARCH 2026, ONE PATIENT EXPERIENCED STRIAE FLAP DISPLACEMENT IN ONE EYE. THE PATIENT HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. NOTE: THIS REPORT IS FOR THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING SUBMITTED FOR THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25326756 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN JULY AND DECEMBER 2023, ONE PATIENT EXPERIENCED STRIAE FLAP DISPLACEMENT IN ONE EYE. THE PATIENT HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. THIS REPORT IS FOR THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING SUBMITTED FOR THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25326634 ↗
• InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) 2024, A PATIENT EXPERIENCED STRIAE FLAP DISPLACEMENT IN ONE EYE. THE PATIENT HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE THIS REPORT IS FOR THE PATIENT INTERFACE. A SEPARATE REPORT IS BEING SUBMITTED FOR THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25326599 ↗
• InjuryMay 29, 2026Mechanical Problem

  IT WAS REPORTED THAT AFTER THE PATIENT WAS TREATED WITH THE IFS FEMTOSECOND LASER HAD TO RETURN TO THE CLINIC FOR FLAP LIFT, WASH AND RINSE. THE CLINIC REPORTED THE INTRODUCTION OF A NEW BATCH OF PATIENT INTERFACES (PI) WHICH HAD DOCKING DIFFERENCES. NO FURTHER INFORMATION WAS PROVIDED. ADDITIONAL INFORMATION HAS BEEN REPORTED WITHOUT INFORMATION AS TO WHAT PATIENT IT RELATES TO. DUE TO THIS, THE BELOW HAS BEEN ADDED TO ALL RELEVANT COMPLAINT FILES TO ENSURE EVENT CAPTURED COMPLETELY. STRIAE FLAP DISPLACEMENT. THIS REPORT IS FOR THE IFS FEMTOSECOND LASER. A SEPARATE REPORT IS BEING SUBMITTED FOR THE PATIENT INTERFACE.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25326532 ↗
• MalfunctionMay 29, 2026Decrease in Suction; Device Difficult to Setup or Prepare

  IT WAS REPORTED THAT WHILE USING THE PATIENT INTERFACE (PI) THE SURGEON FOUND THE DEVICE TO BE VERY STIFF WHICH MADE PLACEMENT CHALLENGING. DUE TO THIS, THE DEVICE WOULD NOT MAINTAIN SUCTION SO WAS REPLACED WITH A BACK UP. THE SURGEON ALSO REPORTED THE REPLACEMENT DEVICE TO BE VERY STIFF. THERE WAS NO PATIENT INJURY AND THE PROCEDURE WAS COMPLETED WITHOUT FURTHER ISSUE. NO FURTHER INFORMATION WAS PROVIDED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 25326464 ↗
• InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) 2025, FOUR PATIENTS EXPERIENCED STRIAE FLAP DISPLACEMENT IN UNKNOWN EYE. THE PATIENTS HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE: THIS REPORT PERTAINS TO THE PATIENT INTERFACE FOR ONE OF THE FOUR PATIENTS. A SEPARATE REPORT IS BEING SUBMITTED FOR THE ASSOCIATED IFS FEMTOSECOND LASER. ADDITIONALLY, SEPARATE REPORTS ARE BEING SUBMITTED FOR THE PATIENT INTERFACE FOR THE REMAINING THREE PATIENTS, AS WELL AS THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25325819 ↗
• InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) 2025, FOUR PATIENTS EXPERIENCED STRIAE FLAP DISPLACEMENT IN UNKNOWN EYE. THE PATIENTS HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE: THIS REPORT PERTAINS TO THE PATIENT INTERFACE FOR ONE OF THE FOUR PATIENTS. A SEPARATE REPORT IS BEING SUBMITTED FOR THE ASSOCIATED IFS FEMTOSECOND LASER. ADDITIONALLY, SEPARATE REPORTS ARE BEING SUBMITTED FOR THE PATIENT INTERFACE FOR THE REMAINING THREE PATIENTS, AS WELL AS THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25325817 ↗
• InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) 2025, FOUR PATIENTS EXPERIENCED STRIAE FLAP DISPLACEMENT IN UNKNOWN EYE. THE PATIENTS HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE: THIS REPORT PERTAINS TO THE PATIENT INTERFACE FOR ONE OF THE FOUR PATIENTS. A SEPARATE REPORT IS BEING SUBMITTED FOR THE ASSOCIATED IFS FEMTOSECOND LASER. ADDITIONALLY, SEPARATE REPORTS ARE BEING SUBMITTED FOR THE PATIENT INTERFACE FOR THE REMAINING THREE PATIENTS, AS WELL AS THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25325804 ↗
• InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) AND (B)(6) 2025, FOUR PATIENTS EXPERIENCED STRIAE FLAP DISPLACEMENT IN UNKNOWN EYE. THE PATIENTS HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE: THIS REPORT PERTAINS TO THE PATIENT INTERFACE FOR ONE OF THE FOUR PATIENTS. A SEPARATE REPORT IS BEING SUBMITTED FOR THE ASSOCIATED IFS FEMTOSECOND LASER. ADDITIONALLY, SEPARATE REPORTS ARE BEING SUBMITTED FOR THE PATIENT INTERFACE FOR THE REMAINING THREE PATIENTS, AS WELL AS THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25325550 ↗
• InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT FOLLOWING TREATMENT WITH THE IFS FEMTOSECOND LASER BETWEEN (B)(6) 2025, SIX PATIENTS EXPERIENCED STRIAE FLAP DISPLACEMENT IN UNKNOWN EYE. THE PATIENTS HAD TO RETURN FOR FLAP LIFT, WASH AND RINSE. NO FURTHER INFORMATION WAS PROVIDED. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS OBTAINED; HOWEVER, IT IS UNCLEAR TO WHICH OF THE PATIENTS THIS INFORMATION PERTAINS. THEREFORE, THIS INFORMATION IS BEING INCLUDED IN ALL CORRESPONDING COMPLAINT FILES. ONE (1) PATIENT HAS LEFT EYE (OS) BEST CORRECTED VISUAL ACUITY (BCVA) PREOP 6/6 AND 6/7 POST FLAP LIFT. THE REST HAVE ACHIEVED UNCORRECTED VISUAL ACUITY (UCVA) POST FLAP LIFT 6/6 OR ABOVE. ONE WITH UCVA 6/7.5 AND BCVA OF 6/6. NO ONE LOST MORE THAN 2 LINES OF BCVA. NOTE: THIS REPORT PERTAINS TO THE PATIENT INTERFACE FOR ONE OF THE SIX PATIENTS. A SEPARATE REPORT IS BEING SUBMITTED FOR THE ASSOCIATED IFS FEMTOSECOND LASER. ADDITIONALLY, SEPARATE REPORTS ARE BEING SUBMITTED FOR THE PATIENT INTERFACE FOR THE REMAINING FIVE PATIENTS, AS WELL AS THE IFS FEMTOSECOND LASER.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

  MAUDE report 25324330 ↗

Other Johnson & Johnson Surgical Vision, Inc. products

• TECNIS IOL1,344 models · 10,702 reports · 3 recalls
• TECNIS SIMPLICITY112 models · 2,730 reports · 1 recall
• SENSAR IOL112 models · 1,213 reports
• TECNIS CL IOL42 models · 558 reports
• TECNIS ODYSSEY IOL49 models · 389 reports
• TECNIS ODYSSEY TORIC II IOL106 models · 285 reports
• UNFOLDER EMERALD2 models · 258 reports
• LAMINAR13 models · 203 reports · 1 recall